Clinical Trial Update: Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating nephrotoxicity of iopamidol versus iodixanol in high-risk patients with chronic kidney disease; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• IOPAMIDOL (IOPAMIDOL)
• VISIPAQUE (IODIXANOL)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Chronic Renal Disease | Phase 4 | Status: TERMINATED